Skip to content

Candlr

All Your Cannabis & Psychedelic News in One Place

Category: News

March 5, 2021

Naturally Splendid Warrant Exercise Raises $254,980

Continue reading →
March 5, 2021

Core One Labs’ Subsidiary Vocan to Work with Former Canopy CEO Mr. Marcelo Galvão to License Bioynthesized Psilocybin in Brazil

Continue reading →
March 5, 2021

MYM Nutraceuticals Inc.: Highland Grow Expands Distribution into Nunavut

Continue reading →
March 5, 2021

TILT Holdings Inc. Announces the Launch of Her Highness NYC Branded THC Products in Massachusetts Market Within 30 Days of Contract Signing

Continue reading →
March 5, 2021

The Valens Company Closes Acquisition of LYF Food Technologies Inc. and Enters Edibles Category with Launch of Soft Chews

Continue reading →
March 5, 2021

Cresco Labs to Report Fourth Quarter and Full Year 2020 Financial Results on March 25th, 2021

Continue reading →
March 5, 2021

BC Craft Supply Closes Definitive Agreement to acquire Ava Pathways

Continue reading →
March 5, 2021

Halo Collective Provides Update on Bophelo Bioscience

Continue reading →
March 5, 2021

Delta 9 Achieves Milestone in Agreement with Micro Cultivation Partner

Continue reading →

Posts navigation

← Older posts

Menu

  • Home
  • About Candlr
    • Legal Disclaimer
    • Services
  • Blog
  • News
  • Featured Companies
    • InnoCan Pharma
    • Water Ways Technologies
    • Naturally Splendid Enterprises
    • Freedom Cannabis
  • Psychedelic Sector
  • Cannabis Sector
  • Contact

Enter your email address to get early access to Candlr app.

Join 4,153 other followers

About Candlr

Candlr is an Investment & Marketing firm developing the best in class stock screener app for traders and investors.

For early access to Candlr app please subscribe HERE.

Hours & Info

1161 W Georgia St, Vancouver, BC V6E 0C6
Info@cannabis-investment-group.com

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,153 other followers

Create a website or blog at WordPress.com
Cancel

 
Loading Comments...
Comment
    ×